Lyme Disease Global Clinical Trials Review, H2, 2017

GlobalData's clinical trial report, “Lyme Disease Global Clinical Trials Review, H2, 2017" provides an overview of Lyme Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Lyme Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Valneva SE

Jubilant Life Sciences Ltd

Ixodes GmbH

Baxter International Inc

Appletree AG (Inactive)

Alkem Laboratories Ltd

First Medical Associates Inc

Daito Pharmaceutical Co Ltd ...

Valneva SE

Jubilant Life Sciences Ltd

Ixodes GmbH

Baxter International Inc

Appletree AG (Inactive)

Alkem Laboratories Ltd

First Medical Associates Inc

Daito Pharmaceutical Co Ltd

China National Pharmaceutical Group Corp

Celerion Inc

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region ...

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Clinical Trials by G7 Countries: Proportion of Lyme Disease to Infectious Disease Clinical Trials 14

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Lyme Disease to Infectious Disease Clinical Trials 18

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Lyme Disease Therapeutics Clinical Trials 29

Prominent Drugs 31

Clinical Trial Profile Snapshots 32

Appendix 57

Abbreviations 57

Definitions 57

Research Methodology 58

Secondary Research 58

About GlobalData 59

Contact Us 59

Source 60

List of Tables

Lyme Disease Therapeutics, Global, Clinical Trials by Region, 2017* 7

Lyme Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Lyme ...

Lyme Disease Therapeutics, Global, Clinical Trials by Region, 2017* 7

Lyme Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Lyme Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

Lyme Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 11

Lyme Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12

Lyme Disease Therapeutics Clinical Trials, North America, Top Countries, 2017* 13

Proportion of Lyme Disease to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 14

Lyme Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Lyme Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17

Proportion of Lyme Disease to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18

Lyme Disease Therapeutics, Global, Clinical Trials by Phase, 2017* 20

Lyme Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21

Lyme Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22

Lyme Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24

Lyme Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25

Lyme Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26

Lyme Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27

Lyme Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29

Lyme Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31

List of Figures

Lyme Disease Therapeutics, Global, Clinical Trials by Region (%), 2017* 7

Lyme Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8 ...

Lyme Disease Therapeutics, Global, Clinical Trials by Region (%), 2017* 7

Lyme Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Lyme Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

Lyme Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12

Proportion of Lyme Disease to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 14

Lyme Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Lyme Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17

Proportion of Lyme Disease to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18

Lyme Disease Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20

Lyme Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21

Lyme Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22

Lyme Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24

Lyme Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25

Lyme Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26

Lyme Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27

Lyme Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29

Lyme Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31

GlobalData Methodology 58

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports